Literature DB >> 25862151

Attachment security and recent stressful life events predict oxytocin levels: a pilot study of pregnant women with high levels of cumulative psychosocial adversity.

Simcha Samuel1, Barbara Hayton, Ian Gold, Nancy Feeley, C Sue Carter, Phyllis Zelkowitz.   

Abstract

PURPOSE: Recent reports indicate that prenatal levels of the neuropeptide oxytocin (OT) are inversely related to depressive symptomatology and positively associated with more optimal interactive behaviors in mothers with high levels of cumulative psychosocial adversity (CPA). In the present pilot study, we aimed to identify factors associated with high versus low levels of OT in pregnant women with high levels of CPA. We hypothesized that insecurely attached women, and those who recently experienced stressful life events (SLE), would have lower levels of prenatal OT.
METHODS: Thirty pregnant women with mood and anxiety disorders and high levels of CPA were recruited from the perinatal mental health service of a general hospital. Participants completed self-report measures of psychosocial stress and adult attachment style, and blood was then drawn to assess OT. RESULTS AND
CONCLUSIONS: Lower OT levels were found among those who were insecurely attached, and among those who experienced SLE within the last year. In a multiple linear regression, both attachment security and SLE significantly contributed to a model of prenatal OT levels. These individual difference factors explained 38% of the variance in prenatal OT, which may in turn predict poorer maternal mental health and caregiving outcomes during the postpartum period.

Entities:  

Keywords:  adversity; attachment; mood and anxiety disorders; oxytocin; pregnancy

Mesh:

Substances:

Year:  2015        PMID: 25862151     DOI: 10.1080/14616734.2015.1029951

Source DB:  PubMed          Journal:  Attach Hum Dev        ISSN: 1461-6734


  8 in total

Review 1.  Oxytocin and Maternal Brain Plasticity.

Authors:  Sohye Kim; Lane Strathearn
Journal:  New Dir Child Adolesc Dev       Date:  2016-09

Review 2.  Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways.

Authors:  Sohye Kim; Stephanie Kwok; Linda C Mayes; Marc N Potenza; Helena J V Rutherford; Lane Strathearn
Journal:  Ann N Y Acad Sci       Date:  2016-08-10       Impact factor: 5.691

3.  Associations between oxytocin receptor gene (OXTR) methylation, plasma oxytocin, and attachment across adulthood.

Authors:  Natalie C Ebner; Tian Lin; Melis Muradoglu; Devon H Weir; Gabriela M Plasencia; Travis S Lillard; Hossein Pournajafi-Nazarloo; Ronald A Cohen; C Sue Carter; Jessica J Connelly
Journal:  Int J Psychophysiol       Date:  2018-02-02       Impact factor: 2.997

4.  Postpartum Depressive Symptoms as a Mediator Between Intimate Partner Violence During Pregnancy and Maternal-Infant Bonding in Japan.

Authors:  Soim Park; M Claire Greene; Melissa K Melby; Takeo Fujiwara; Pamela J Surkan
Journal:  J Interpers Violence       Date:  2019-09-18

5.  Association of oxytocin level and less severe forms of childhood maltreatment history among healthy Japanese adults involved with child care.

Authors:  Rie Mizuki; Takeo Fujiwara
Journal:  Front Behav Neurosci       Date:  2015-06-23       Impact factor: 3.558

6.  Traumatic events: exploring associations with maternal depression, infant bonding, and oxytocin in Latina mothers.

Authors:  Sandraluz Lara-Cinisomo; Kefu Zhu; Kexin Fei; Yumeng Bu; Alexandria P Weston; Uma Ravat
Journal:  BMC Womens Health       Date:  2018-02-01       Impact factor: 2.809

Review 7.  Pathways Relating the Neurobiology of Attachment to Drug Addiction.

Authors:  Lane Strathearn; Carol E Mertens; Linda Mayes; Helena Rutherford; Purva Rajhans; Guifeng Xu; Marc N Potenza; Sohye Kim
Journal:  Front Psychiatry       Date:  2019-11-08       Impact factor: 4.157

8.  Investigating the relationship between COVID-19-related and distress and ICD-11 adjustment disorder: two cross-sectional studies.

Authors:  Menachem Ben-Ezra; Wai Kai Hou; Robin Goodwin
Journal:  BJPsych Open       Date:  2020-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.